Going forward, analysts remain positive on the company and believe it is highly levered to potential revival in urban demand. This, coupled with the company's efforts, could push volumes, albeit gradually. Continued softness in input costs, further price hikes and improving mix in favour of high-margin products such as Maggi, Lactogen (infant nutrition) could provide additional impetus to margins going forward. Nestle's focus on premiumisation across its portfolio (chocolates, confectioneries, prepared dishes, beverages, milk) augur well for its margins going forward. While the company is stepping up innovation to push volumes and increase its competitive positioning, analysts will keenly eye the success of these efforts.
At Friday's closing price of Rs 7,013, Nestle scrip trades at 44.9 times CY15 estimated earnings and appears to be fairly valued.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)